Alkermes (NASDAQ:ALKS – Free Report) had its price objective increased by Cantor Fitzgerald from $43.00 to $48.00 in a research report report published on Thursday morning, Benzinga reports. The brokerage currently has an overweight rating on the stock. Several other research analysts also recently commented on ALKS. HC Wainwright reaffirmed a neutral rating and issued […]